11-[4-(4,6-diphenyl-1,3-diaza-5-azanidacyclohex-2-yl)phenyl]-[1]benzothiolo[3,2-b]carbazole
C39H29N4S- — CID 163885419
Data last refreshed: (MolForge compound catalog, from PubChem)
About 11-[4-(4,6-diphenyl-1,3-diaza-5-azanidacyclohex-2-yl)phenyl]-[1]benzothiolo[3,2-b]carbazole
11-[4-(4,6-diphenyl-1,3-diaza-5-azanidacyclohex-2-yl)phenyl]-[1]benzothiolo[3,2-b]carbazole (PubChem CID 163885419) has the molecular formula C39H29N4S- and a molecular weight of 585.76 g/mol. Its IUPAC name is 11-[4-(4,6-diphenyl-1,3-diaza-5-azanidacyclohex-2-yl)phenyl]-[1]benzothiolo[3,2-b]carbazole.
Molecular Properties
| Compound Name | 11-[4-(4,6-diphenyl-1,3-diaza-5-azanidacyclohex-2-yl)phenyl]-[1]benzothiolo[3,2-b]carbazole |
|---|---|
| PubChem CID | 163885419 |
| Molecular Formula | C39H29N4S- |
| Molecular Weight | 585.76 g/mol |
| Exact Mass | 585.21 |
| IUPAC Name | 11-[4-(4,6-diphenyl-1,3-diaza-5-azanidacyclohex-2-yl)phenyl]-[1]benzothiolo[3,2-b]carbazole |
| SMILES | c1ccc(C2[N-]C(c3ccccc3)NC(c3ccc(-n4c5ccccc5c5cc6sc7ccccc7c6cc54)cc3)N2)cc1 |
| InChI | InChI=1S/C39H29N4S/c1-3-11-25(12-4-1)37-40-38(26-13-5-2-6-14-26)42-39(41-37)27-19-21-28(22-20-27)43-33-17-9-7-15-29(33)31-24-36-32(23-34(31)43)30-16-8-10-18-35(30)44-36/h1-24,37-39,41-42H/q-1 |
| InChIKey | PWXHERLEJHBHRB-UHFFFAOYSA-N |
| XLogP | 10.11 |
| TPSA | 43.09 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 585.76 |
| LogP ≤ 5 | 10.11 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163885419 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.